Most Read This Week
- Efficacy and Safety of Tacrolimus Use in Patients With Dermatomyositis/Polymyositis
- Perspectives on Treatment Burden of Methotrexate and Tumor Necrosis Factor Inhibitor Use Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
- Effect of Nintedanib Use in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease and Risk Factors for Rapid Progression
- Familial Risk of Gout and Interaction With Obesity and Alcohol Consumption
- Anti-CCAR1 Autoantibodies Are Specific for Anti–TIF1-γ Antibody–Positive Dermatomyositis and Decrease Cancer Risk Relative to the General Population
Recently Updated
- Toxicity Outcomes in Patients With ANCA-Associated Vasculitis Treated With Avacopan vs Standard Prednisone Taper
- Effect of Nintedanib Use in Patients With Systemic Sclerosis–Associated Interstitial Lung Disease and Risk Factors for Rapid Progression
- Association Between Autoimmune Rheumatic Diseases and Head and Neck Cancer
- Efficacy and Safety of Tacrolimus Use in Patients With Dermatomyositis/Polymyositis
- Efficacy of the PET Vascular Activity Score for Predicting New Angiographic Lesions in Patients With Takayasu Arteritis